These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7532742

  • 1. Clinical value of fructose 1,6 bisphosphatase in monitoring renal proximal tubular injury.
    Pfaller W, Thorwartl U, Nevinny-Stickel M, Krall M, Schober M, Joannidis M, Hobisch A.
    Kidney Int Suppl; 1994 Nov; 47():S68-75. PubMed ID: 7532742
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT, Fels LM, Franzke A, Knop S, Renn M, Maess B, Panagiotou P, Lampe H, Kanz L, Stolte H, Bokemeyer C.
    Anticancer Res; 2000 Nov; 20(5C):3767-73. PubMed ID: 11268452
    [Abstract] [Full Text] [Related]

  • 3. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C, Bosomworth M, Clifton I, Peckham DG, Conway SP.
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [Abstract] [Full Text] [Related]

  • 4. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.
    Haschke M, Vitins T, Lüde S, Todesco L, Novakova K, Herrmann R, Krähenbühl S.
    Nephrol Dial Transplant; 2010 Feb 15; 25(2):426-33. PubMed ID: 19736245
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support.
    Elias AD, Ayash LJ, Wheeler C, Schwartz G, Tepler I, Gonin R, McCauley M, Mazanet R, Schnipper L, Frei E.
    Bone Marrow Transplant; 1995 Mar 15; 15(3):373-9. PubMed ID: 7599561
    [Abstract] [Full Text] [Related]

  • 7. Changes in the structure and function of the kidney of rats chronically exposed to cadmium. I. Biochemical and histopathological studies.
    Brzóska MM, Kamiński M, Supernak-Bobko D, Zwierz K, Moniuszko-Jakoniuk J.
    Arch Toxicol; 2003 Jun 15; 77(6):344-52. PubMed ID: 12799774
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.
    Goren MP, Wright RK, Pratt CB, Horowitz ME, Dodge RK, Viar MJ, Kovnar EH.
    Cancer Res; 1987 Mar 01; 47(5):1457-60. PubMed ID: 3815347
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin nephrotoxicity and protection by silibinin.
    Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H.
    Nephrol Dial Transplant; 1996 Jan 01; 11(1):55-62. PubMed ID: 8649653
    [Abstract] [Full Text] [Related]

  • 10. The influence of age on nephrotoxicity following chemotherapy in children.
    Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW.
    Br J Cancer Suppl; 1992 Aug 01; 18():S30-5. PubMed ID: 1503924
    [Abstract] [Full Text] [Related]

  • 11. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W.
    Bone Marrow Transplant; 1997 Nov 01; 20(10):813-9. PubMed ID: 9404920
    [Abstract] [Full Text] [Related]

  • 12. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function].
    Skrezek C, Bertermann H, Schulz FP, König B.
    Urologe A; 1990 Jan 01; 29(1):27-31. PubMed ID: 2316078
    [Abstract] [Full Text] [Related]

  • 13. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
    Ujiie T, Maruta H, Ito N.
    Hinyokika Kiyo; 1988 May 01; 34(5):790-6. PubMed ID: 2459938
    [Abstract] [Full Text] [Related]

  • 14. Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment.
    Hacke M, Schmoll HJ, Alt JM, Baumann K, Stolte H.
    Clin Physiol Biochem; 1983 May 01; 1(1):17-26. PubMed ID: 6383688
    [Abstract] [Full Text] [Related]

  • 15. [Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
    Kitamura Y, Watanabe M, Komatsubara S, Sakata Y.
    Hinyokika Kiyo; 1993 Feb 01; 39(2):135-40. PubMed ID: 7682030
    [Abstract] [Full Text] [Related]

  • 16. [Studies on renal dysfunction after intra-arterial hypertensive chemotherapy (CDDP, PEP) for advanced cancer of the uterine cervix--serum.urinary alpha 1-microglobulin, beta 2-microglobulin and urinary lysozyme, albumin].
    Iwanari O, Date Y, Yoshino N, Miyako J, Ryuhkoh K, Moriyama M, Nakayama S, Kitao M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb 01; 42(2):115-20. PubMed ID: 1690251
    [Abstract] [Full Text] [Related]

  • 17. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
    Gormley SM, McBride WT, Armstrong MA, McClean E, MacGowan SW, Campalani G, McMurray TJ.
    Cytokine; 2002 Jan 21; 17(2):61-5. PubMed ID: 11886172
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Early urinary markers of target nephron segments as studied in cadmium toxicity.
    Fels LM, Bundschuh I, Gwinner W, Jung K, Pergande M, Graubaum HJ, Price RG, Taylor SA, De Broe ME, Nuyts GD.
    Kidney Int Suppl; 1994 Nov 21; 47():S81-8. PubMed ID: 7869678
    [Abstract] [Full Text] [Related]

  • 20. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I, Krzymański M.
    Przegl Lek; 1996 Nov 21; 53(5):443-53. PubMed ID: 8754411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.